Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Ophthalmol ; 118(2): 145-51, 1994 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-8053459

RESUMO

Rochalimaea henselae and R. quintana belong to the order Rickettsiales and are thought to be responsible for trench fever, bacillary angiomatosis, and cat scratch disease. We recently examined four patients with intraocular inflammation of unknown origin. Each patient had either unilateral or bilateral moderate loss of visual acuity ranging from 20/25 to counting fingers. Bilateral intraocular inflammation manifested by anterior and posterior segment cells, retinal lesions, macular exudate, and optic nerve head swelling was present to varying degrees. The R. henselae to R. quintana antibody titers were greater than or equal to 1:256 in each case. Marked improvement in vision occurred after treatment with either oral ciprofloxacin hydrochloride and prednisone or doxycycline hyclate. Rochalimaea species should be considered in the differential diagnosis of intraocular inflammation and inflammatory optic neuropathy. Appropriate treatment may result in marked improvement in visual acuity.


Assuntos
Infecções por Bartonella/diagnóstico , Endoftalmite/diagnóstico , Infecções Oculares Bacterianas/diagnóstico , Adolescente , Adulto , Alphaproteobacteria/imunologia , Anticorpos Antibacterianos/análise , Infecções por Bartonella/tratamento farmacológico , Ciprofloxacina/uso terapêutico , Doxiciclina/uso terapêutico , Quimioterapia Combinada , Endoftalmite/tratamento farmacológico , Endoftalmite/microbiologia , Exsudatos e Transudatos , Infecções Oculares Bacterianas/tratamento farmacológico , Feminino , Fundo de Olho , Humanos , Masculino , Pessoa de Meia-Idade , Papiledema/diagnóstico , Prednisona/uso terapêutico , Doenças Retinianas/diagnóstico , Doenças Retinianas/microbiologia , Acuidade Visual
2.
Hepatology ; 8(3): 585-90, 1988.
Artigo em Inglês | MEDLINE | ID: mdl-3371875

RESUMO

Trypan blue uptake and lactate dehydrogenase release were measured as indices of irreversible cell damage in isolated, perfused rat livers during low-flow hypoxia. In livers from fasted rats perfused in the anterograde direction, trypan blue uptake took place beginning at about 45 min of hypoxia. Cells which took up trypan blue first were located in narrow bands at the border between anoxic pericentral areas and normoxic periportal regions of the liver lobule. After longer periods of hypoxia, trypan blue uptake progressed towards the central vein until after 120 min virtually all cells in the pericentral regions were stained. Under these conditions, cells in periportal regions were spared. In perfusions in the retrograde direction, cell death began in midzonal regions and spread towards the portal vein. Release of lactate dehydrogenase into the effluent paralleled trypan blue uptake, beginning at about 40 min of low-flow hypoxia and peaking at 80 min. In contrast to livers from fasted rats, trypan blue was not taken up, and lactate dehydrogenase was not released in livers from fed rats exposed to low-flow hypoxia for as long as 120 min. To test the hypothesis that xanthine oxidase-mediated oxygen-free radical formation was involved in cell injury at the border between anoxic and normoxic regions (anoxic edge), allopurinol, an inhibitor of xanthine oxidase, was studied. Allopurinol (0.2 to 5 mM) delayed the release of lactate dehydrogenase during low-flow hypoxia in a dose-dependent fashion (e.g., 5 mM allopurinol delayed hypoxia-induced lactate dehydrogenase release by about 30 min).(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Alopurinol/farmacologia , Hipóxia/metabolismo , Fígado/metabolismo , Animais , Sobrevivência Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Jejum , Hipóxia/patologia , L-Lactato Desidrogenase/metabolismo , Fígado/efeitos dos fármacos , Fígado/patologia , Masculino , Perfusão , Ratos , Ratos Endogâmicos , Fatores de Tempo , Azul Tripano/farmacocinética , Xantina Oxidase/antagonistas & inibidores , Xantina Oxidase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...